Popular on PrZen
- Meta Partnership Expanding as Omni One Orders Surge 3X -New Consumer Bundles, Defense Opportunities & AI Robotics: Virtuix Holdings: N A S D A Q: VTIX - 614
- OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki - 611
- Alan Hamilton of Shiver Hamilton Campbell Inducted as a Fellow of the American College of Trial Lawyers - 610
- The 4th Annual Newark Summit for Economic Development, Placemaking & Innovation Returns on December 8th - 608
- Club Wyndham Research Identifies the "Holiday Rewind Effect": 93% of Parents Recreate Their Own Childhood Holidays for Their Kids - 582
- Citizens for West Virginia Election Integrity Urges "FOR" on Amendment 1 - 569
- "The Tree of Cinema" Installation Brought Film History and Its Audiences Together at TIFF 2026 - 546
- Creole101 Launches Multilingual Dictionary App with 50,000+ Entries, Vocabulary Games and Haitian Cultural Resources - 531
- 450 Million Revenue Run Rate, Global Telecom Reach and a New Digital Growth Opportunity Take Center Stage: IQSTEL, Inc. (N A S D A Q: IQST) - 524
- New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA? - 522
Similar on PrZen
- Commercial Sales Launch Following FDA Approval; National Sales Force Now in Action as January Shipments and Major Market Opportunity Take Shape
- Contracting Resources Group Named a 2027 Elev8 GovCon Honoree by OrangeSlices
- Qscription Technologies Welcomes Joanna Krause, MD, MRMD to Its Clinical Advisory Board
- New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA?
- OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
- Bacchus Wine & Spirits and Michelin Guide–Recommended Ethel's Fancy to Host Exclusive LOUIS XIII Limited Edition Diwali Decanter Celebration
- New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
- New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
- FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
- AthleteMerch.com Surpasses 100,000 Custom Items Delivered to Fans Nationwide
Amaris Mint® Confirms UK Availability of Swedish-Made BioBoost Daily Nutrition Range
PrZen/33622874
The clinician-founded brand brings together daily protein and food supplements, with clear product information and manufacturing in Sweden.
LONDON - PrZen -- Amaris Mint Ltd has confirmed that its BioBoost nutrition range is available to UK customers through its online store. The products have been available in the UK since April 2026.
Founded by Dr Nillie Teymouri and Tina Hirst, Amaris Mint® describes its approach as Swedish Daily Nutrition: thoughtfully formulated products, clear labelling and routines designed to fit into everyday life.
The range includes BioBoost Balance+ Protein, a daily nutrition protein powder available in Vanilla, Cinnamon and Chai. Supplied in 750 g pouches, the formulation combines whey protein with collagen peptides, vitamins, minerals, fibre, live cultures, digestive enzymes and selected botanicals. It contains more than 30 carefully selected ingredients.
The range also includes BioBoost Vital Balance, a clinician-formulated food supplement combining resveratrol, spirulina, vitamin D3, zinc and other selected ingredients. Each bottle contains 60 capsules. Current orders of BioBoost Vital Balance are supplied in bottles labelled BioBoost InflamGuard.
Amaris Mint's approach centres on helping customers make daily protein and nutrition part of a consistent routine. Full ingredient lists, allergen information and directions for use are available on the individual product pages.
The products are clinician-formulated and manufactured in Sweden at an FSSC 22000-certified facility. The certification applies to the manufacturing facility.
The BioBoost range is available at https://amarismint.com/
Food supplements should complement a varied, balanced diet and healthy lifestyle and should not be used as a substitute for either.
About Amaris Mint
Amaris Mint is a clinician-founded Swedish Daily Nutrition brand with a focus on daily protein, clear product information and Swedish manufacturing. Product photographs and founder interviews are available on request. Retail, clinic and distribution enquiries are welcome.
Founded by Dr Nillie Teymouri and Tina Hirst, Amaris Mint® describes its approach as Swedish Daily Nutrition: thoughtfully formulated products, clear labelling and routines designed to fit into everyday life.
The range includes BioBoost Balance+ Protein, a daily nutrition protein powder available in Vanilla, Cinnamon and Chai. Supplied in 750 g pouches, the formulation combines whey protein with collagen peptides, vitamins, minerals, fibre, live cultures, digestive enzymes and selected botanicals. It contains more than 30 carefully selected ingredients.
The range also includes BioBoost Vital Balance, a clinician-formulated food supplement combining resveratrol, spirulina, vitamin D3, zinc and other selected ingredients. Each bottle contains 60 capsules. Current orders of BioBoost Vital Balance are supplied in bottles labelled BioBoost InflamGuard.
Amaris Mint's approach centres on helping customers make daily protein and nutrition part of a consistent routine. Full ingredient lists, allergen information and directions for use are available on the individual product pages.
The products are clinician-formulated and manufactured in Sweden at an FSSC 22000-certified facility. The certification applies to the manufacturing facility.
The BioBoost range is available at https://amarismint.com/
Food supplements should complement a varied, balanced diet and healthy lifestyle and should not be used as a substitute for either.
About Amaris Mint
Amaris Mint is a clinician-founded Swedish Daily Nutrition brand with a focus on daily protein, clear product information and Swedish manufacturing. Product photographs and founder interviews are available on request. Retail, clinic and distribution enquiries are welcome.
Source: Amaris Mint Ltd
0 Comments
Latest on PrZen
- The Fifth Annual "Bamboo Lantern Festival" to Illuminate Tokyo Mizumachi and Sumida River Walk®
- Iglesia.com Positioned in Multimillion-Dollar Domain Market with $10 Million Asking Price
- TCA VG: 2025 Funding Climbs to $9M across 43 Companies; Cumulative Returns Reach 5.3 MOIC & 22% IRR
- Searching for the Next LBE Creator: CalArts Launches First-Ever D.R.E.A.M.S. Pitch Competition
- Integris Composites Joins International Sea Power Conference Aboard HMS Prince of Wales
- Commercial Sales Launch Following FDA Approval; National Sales Force Now in Action as January Shipments and Major Market Opportunity Take Shape
- ViewDNS.info Launches Monitors, Alerting Teams the Moment Something Changes on Their Domains
- Philadelphia-Area Entrepreneur Nouho M Kanneh Builds $37 Million Net Worth Across Real Estate, E-Commerce and Retail
- Contracting Resources Group Named a 2027 Elev8 GovCon Honoree by OrangeSlices
- The World's No.1 Superstar® Brings Christmas Back in Grand Style with Music, Cinematic Glamour, and Luxury Fashion
- New Six-Figure Media Agreement Builds Powerful Momentum, Expanding Government Contracts, FBI Access and Growing AI Recognition: Cyabra (NAS DAQ: CYAB)
- Christmas Beats Summer in Paris: Travel Photoshoots Peak on Dec. 30
- Qscription Technologies Welcomes Joanna Krause, MD, MRMD to Its Clinical Advisory Board
- Jamie Foxx's SKVLK Fest Sets the Record Straight on Stabbing Reports Following Star-Studded Celebration
- Andrew Balzano Releases One of My Life's Passions: Classics and Mysteries, a Fan's Guide to Great Mysteries Worth Rewatching
- The 4th Annual Newark Summit for Economic Development, Placemaking & Innovation Returns on December 8th
- Romanian Software Company ASSIST Software Ranks Second Nationally Among Large Enterprises in Its Category
- HIRO Ostomy Belt Launch by Richard O'Hamill
- New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA?
- Technical Brief Examines Enterprise Integration Challenges as AI Agent Platforms Expand




